An interventional study of TB1-K in Kidney Preservation and Transportation, sponsored by Transplant Biomedicals, S.L.. Status unknown at 3 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-06-21.
Sponsored by Transplant Biomedicals, S.L. · Not applicable, Interventional, and Other
TB1-K Device is an organ preservation and transportation system, using ultrasound technology with a cooling system to preserve the organ in optimal conditions during transport to the transplant recipient.
This is a prospective, single-arm, multi-center study comparing to a historical control for cold storage.
The study is conducted in accordance with the Standard ISO 14155 (Clinical investigation of medical devices for human subjects - Good clinical practice), and other legal requirements.
The study objective is to assess the safety and performance of the TB1-K device in donor kidneys intended for transplantation.
This is the only study on the registry with Transplant Biomedicals, S.L. as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Donor Inclusion Criteria:
Donor meets one of the following:
Donor Exclusion Criteria:
Recipient Inclusion Criteria:
Recipient Exclusion Criteria:
TB1-K preservation arm
Device: TB1-K
Use of TB1-K for preservation and transport of donated kidneys
Rate of DGF
Rate of delayed graft function (DGF), defined as need for dialysis in the first week after transplant, once hyperacute rejection, vascular and urinary tract complications are ruled out.
Time frame: 1 week after transplant
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.